Population-based assessment of oral sumatriptan efficacy and safety in migraine patients

被引：0
|
作者：
Czapinski, P [1 ]
Czapinska, E [1 ]
机构：
[1] Epilepsy & Migraine Treatment Ctr, Krakow, Poland
来源：
CEPHALALGIA | 2005年 / 25卷 / 10期
关键词：
sumatriptan; migraine; acute treatment; efficacy; safety;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：933 / 933
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: Defining the optimum doses of oral sumatriptan
    Pfaffenrath, V
    Cunin, G
    Sjonell, G
    Prendergast, S
    HEADACHE, 1998, 38 (03): : 184 - 190
  • [2] Efficacy and tolerability of oral Sumatriptan in Indian patients with acute migraine; A multicentre study
    Padma, MV
    Jain, S
    Maheshwari, MC
    Misra, S
    Karak, B
    Singh, AK
    Meena, AK
    Katiyar, CK
    Tiwari, P
    NEUROLOGY INDIA, 1998, 46 (02) : 105 - 108
  • [3] The efficacy and safety of sumatriptan intranasal powder in adults with acute migraine
    Freitag, Frederick G.
    Shumate, Derrick Alan
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (07) : 743 - 747
  • [4] Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan
    Färkkilä, M
    Olesen, J
    Dahlöf, C
    Stovner, LJ
    ter Bruggen, JP
    Rasmussen, S
    Muirhead, N
    Sikes, C
    CEPHALALGIA, 2003, 23 (06) : 463 - 471
  • [5] Sumatriptan-Naproxen Migraine Efficacy in Allodynic Patients: Early Intervention
    Landy, Stephen
    Hoagland, Rebecca
    Hoagland, Nancy A.
    HEADACHE, 2012, 52 (01): : 133 - 139
  • [6] The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura
    Miljkovic, S.
    Smajlovic, Dz
    Tiric Campara, M.
    Jurina, R.
    Duranovic Vinkovic, L.
    Jankovic, S. M.
    Begovic, B.
    Ceranic, M.
    HIPPOKRATIA, 2018, 22 (01) : 17 - 22
  • [7] Parenteral vs. oral sumatriptan and naratriptan: Plasma levels and efficacy in migraine. A comment
    Tfelt-Hansen P.
    The Journal of Headache and Pain, 2007, 8 (5) : 273 - 276
  • [8] Effect of a change in lasmiditan dose on efficacy and safety in patients with migraine
    Clemow, David B.
    Hochstetler, Helen M.
    Dong, Yan
    Hauck, Paula
    Peres, Mario F. P.
    Ailani, Jessica
    POSTGRADUATE MEDICINE, 2021, 133 (04) : 449 - 459
  • [9] Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo
    Bussone, G
    Grazzi, L
    D'Amico, D
    Manzoni, C
    Granella, F
    Cortelli, P
    Pierangeli, G
    Canal, N
    Colombo, B
    Frediani, F
    Maltempo, C
    Peruzzi, E
    Edson, K
    Ezzet, N
    Huels, J
    CEPHALALGIA, 1999, 19 (04) : 232 - 240
  • [10] Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients
    Anna Ferrari
    Diego Pinetti
    Alfio Bertolini
    Ciro Coccia
    Emilio Sternieri
    European Journal of Clinical Pharmacology, 2008, 64 : 489 - 495
12345